Addus HomeCare (ADUS) Jefferies 2025 Healthcare Services Conference summary
Event summary combining transcript, slides, and related documents.
Jefferies 2025 Healthcare Services Conference summary
3 Feb, 2026Business overview and growth strategy
Operates in 22 states, focusing on personal care (75% of business), hospice (20%), and home health (5%).
Pursues a full continuum of home-based care, building early relationships with clients to support transitions to higher-acuity services.
Targets 10% annual growth, with half from acquisitions; recent Gentiva deal expanded presence, especially in Texas and Arkansas.
Texas is a key growth market post-acquisition, with significant expansion potential despite current 5% market share.
Organic growth is driven by rate increases and volume, with personal care aiming for 3%-5% top-line growth and clinical segments showing strong performance.
Financial and operational performance
Rate increases in major states like Texas and Illinois have supported above-average growth in recent years.
Volume growth in personal care is targeted at 2%-2.5% annually, with the remainder of growth from rate increases.
Hospice segment is growing near 10%, with long-term expectations in the mid-to-upper single digits.
Home health faces rate pressures but still offers volume growth opportunities.
State relationships and Medicaid dynamics
Maintains strong relationships with supportive states, emphasizing the cost-effectiveness of home care versus nursing homes.
Illinois stands out for both Medicaid and state-funded programs, helping prevent rapid asset spend-down and nursing home admissions.
Acquisition strategy considers state fiscal health, Medicaid management, and demographic trends.
Managed Medicaid relationships and scale enable participation in value-based care and direct rate negotiations.
Latest events from Addus HomeCare
- Hospice recovery, census growth, and tech-driven hiring fuel expansion amid stable rates.ADUS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong Q4 exit, tech-driven efficiency, and robust growth outlook amid regulatory changes.ADUS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Margins, growth, and M&A drive performance as census rebounds and tech boosts fill rates.ADUS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 2025 revenue and EBITDA surged, led by personal care and hospice growth.ADUS
Q4 202524 Feb 2026 - Q2 revenue up 10.4%, net income $18.1M, major equity raise, Gentiva deal, NY divestiture.ADUS
Q2 20242 Feb 2026 - Strong growth, strategic market exits, and value-based care drive expansion and resilience.ADUS
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q3 revenue up 7%, EPS up 13%, with Gentiva deal and NY exit to drive future growth.ADUS
Q3 202416 Jan 2026 - Personal care expansion, M&A, and tech integration drive growth; margins seen at 11-12%.ADUS
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Strong growth, smooth integration, and favorable labor trends set up a robust 2025.ADUS
KeyBanc Annual Healthcare Forum 202526 Dec 2025